STEINMAN LAWRENCE Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$97,396.00
Insider Sells Quantity
6
Insider Sells Sum
$660,986.02

Insider Activity of STEINMAN LAWRENCE

According to the SEC Form 4 filings, STEINMAN LAWRENCE, being in a position of

  1. director at Pasithea Therapeutics Corp.,
    оver the last 12 months, has bought 133333 shares for $100,000, and sold 0 shares,
    over all time since 2023-06-02, has bought 163333 shares for $112,930, and sold 0 shares.

Biography of STEINMAN LAWRENCE

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $100,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2025-11-28PurchasePasithea Therapeutics Corp.
KTTA
director
133,333
0.9139%
$0.75$100,000-52.86%
2023-06-02PurchasePasithea Therapeutics Corp.
KTTA
director
30,000
0.124%
$0.43$12,930-5%
2005-03-02SaleNeurocrine Biosciences, Inc.
NBIX
director
8,000
0.0221%
$41.10$328,829+15.69%
2004-09-15SaleNeurocrine Biosciences, Inc.
NBIX
director
4,000
0.0108%
$50.25$201,018-11.12%
Total: 4
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.